Johnson & Johnson's Novel Targeted Oral Peptide Shines in Phase II Trial for Plaque Psoriasis

Retrieved on: 2024-02-08 17:15:36

Tags for this article:

Click the tags to see associated articles and topics

Johnson & Johnson's Novel Targeted Oral Peptide Shines in Phase II Trial for Plaque Psoriasis. View article details on HISWAI: https://www.pharmexec.com/view/johnson-johnson-s-novel-targeted-oral-peptide-shines-in-phase-ii-trial-for-plaque-psoriasis

Excerpt

... monoclonal antibodies and fusion proteins that act against inflammatory cytokines and their receptors. Because IL-23 has been found to play a ...

Article found on: www.pharmexec.com

View Original Article